Literature DB >> 23237737

Catastrophe risk models for evaluating disaster risk reduction investments in developing countries.

E Michel-Kerjan1, S Hochrainer-Stigler, H Kunreuther, J Linnerooth-Bayer, R Mechler, R Muir-Wood, N Ranger, P Vaziri, M Young.   

Abstract

Major natural disasters in recent years have had high human and economic costs, and triggered record high postdisaster relief from governments and international donors. Given the current economic situation worldwide, selecting the most effective disaster risk reduction (DRR) measures is critical. This is especially the case for low- and middle-income countries, which have suffered disproportionally more economic and human losses from disasters. This article discusses a methodology that makes use of advanced probabilistic catastrophe models to estimate benefits of DRR measures. We apply such newly developed models to generate estimates for hurricane risk on residential structures on the island of St. Lucia, and earthquake risk on residential structures in Istanbul, Turkey, as two illustrative case studies. The costs and economic benefits for selected risk reduction measures are estimated taking account of hazard, exposure, and vulnerability. We conclude by emphasizing the advantages and challenges of catastrophe model-based cost-benefit analyses for DRR in developing countries.
© 2012 Society for Risk Analysis.

Entities:  

Mesh:

Year:  2012        PMID: 23237737     DOI: 10.1111/j.1539-6924.2012.01928.x

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.000


  2 in total

Review 1.  Risk analysis and safety assessment of hospitals against disasters: A systematic review.

Authors:  Seyed Mobin Moradi; Mahmood Nekoei-Moghadam; Ahmad Abbasnejad; Naser Hasheminejad
Journal:  J Educ Health Promot       Date:  2021-11-30

2.  If Numbers Can Speak, Who Listens? Creating Engagement and Learning for Effective Uptake of DRR Investment in Developing Countries.

Authors:  Junko Mochizuki; Adriana Keating; Reinhard Mechler; Callahan Egan; Stefan Hochrainer-Stigler
Journal:  PLoS Curr       Date:  2016-06-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.